| Naslov: | Arterial function is preserved in successfully treated patients with psoriasis vulgaris |
|---|
| Avtorji: | ID Merzel Šabović, Eva Klara (Avtor)
ID Kraner Šumenjak, Tadeja (Avtor)
ID Božič Mijovski, Mojca (Avtor)
ID Janić, Miodrag (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (981,51 KB)
MD5: 927DC2ABF8908F88A972ED8A946069B7
 URL - Izvorni URL, za dostop obiščite https://journals.sagepub.com/doi/10.1177/00368504241287893
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Introduction Endothelial dysfunction is an early precursor of atherosclerosis and is common in patients with psoriasis, presumably primarily due to psoriasis-related inflammation. We investigated endothelial function, arterial stiffness, and circulating markers of endothelial activation in young patients with psoriasis vulgaris of varying severity, all of whom were effectively treated achieving PASI 90. Methods We conducted a cross-sectional study of 80 patients (54 men/26 women, 30–45 years) who were effectively treated with topical therapy, methotrexate, adalimumab, secukinumab or guselkumab, and 20 healthy controls. Endothelial dysfunction was measured by flow-mediated dilation and arterial stiffness was measured by pulse wave velocity and common carotid artery stiffness. The following circulating biomarkers of endothelial activation were measured: ICAM-1, VCAM-1, E- and P-selectin, GDF-15, and TRAIL. Results Endothelial function and arterial stiffness parameters did not differ between patients with effectively treated psoriasis and the control group. Circulating endothelial activation biomarkers did not show relevant differences between the groups of effectively treated patients or controls. Discussion Although cardiovascular disease is the leading cause of morbidity and mortality in patients with psoriasis, effective antipsoriatic treatment appears to slow the progression of atherosclerosis, even when there are cardiovascular risk factors, such as smoking or obesity. This may suggest that antipsoriatic treatment exerts a cardioprotective effect. Conclusions Our results suggest that early and effective treatment of varying-severity psoriasis vulgaris in young patients appears to prevent arterial dysfunction related to psoriasis and consequent cardiovascular risk. |
|---|
| Ključne besede: | psoriasis, young patients, endothelial function, arterial stiffness, antipsoriatic treatment |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | 17 str. |
|---|
| Številčenje: | Vol. 107, iss. 4 |
|---|
| PID: | 20.500.12556/DiRROS-24591  |
|---|
| UDK: | 61 |
|---|
| ISSN pri članku: | 2047-7163 |
|---|
| DOI: | 10.1177/00368504241287893 |
|---|
| COBISS.SI-ID: | 213565699 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 4. 11. 2024;
|
|---|
| Datum objave v DiRROS: | 08.12.2025 |
|---|
| Število ogledov: | 98 |
|---|
| Število prenosov: | 41 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
